Danaher earnings were $4.3B for the trailing 12 months ending Sep 25, 2026, with 25.4% growth year over year. The latest DHR earnings report on Sep 25, 2026 announced Q3 2026 earnings of $1.2B, up 42% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DHR reported annual earnings of $3.6B, with -7.3% growth.
DHR past earnings growth
How has DHR's earnings growth performed historically?
On DHR's earnings call on Oct 21, 2026, Danaher (NYSE: DHR) reported Q3 2026 earnings per share (EPS) of $1.75, up 36.72% year over year. Total DHR earnings for the quarter were $1.24 billion. In the same quarter last year, Danaher's earnings per share (EPS) was $1.28.
As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Sep 25, 2026 was $4.33 billion, a 23.64% increase year over year.
What was DHR's earnings growth in the past year?
As of Danaher's earnings date in Oct 21, 2026, Danaher's earnings has grown 25.41% year over year. This is 14.95 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.46%. DHR earnings in the past year totalled $4.33 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.